Mesalamine - NDC Database (Page 3)
60687-650 Jun 20, 2022
Mesalamine .375 g/1 Oral Capsule, Extended Release by American Health Packaging
Mesalamine .375 g/1 Oral Capsule, Extended Release by American Health Packaging
60687-703 Jan 20, 2023
Mesalamine 500 mg Oral Capsule, Extended Release by American Health Packaging
Mesalamine 500 mg Oral Capsule, Extended Release by American Health Packaging
62332-724 Nov 03, 2022
Mesalamine .375 g/1 Oral Capsule, Extended Release by Alembic Pharmaceuticals Inc.
Mesalamine .375 g/1 Oral Capsule, Extended Release by Alembic Pharmaceuticals Inc.
63304-089 May 13, 2022
Mesalamine 500 mg Oral Capsule, Extended Release by Sun Pharmaceutical Industries Inc.
Mesalamine 500 mg Oral Capsule, Extended Release by Sun Pharmaceutical Industries Inc.
63304-175 Feb 01, 2019
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Sun Pharmaceutical Industries, Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Sun Pharmaceutical Industries, Inc.
67877-717 Jul 16, 2021
Mesalamine .375 g/1 Oral Capsule, Extended Release by Ascend Laboratories, LLC
Mesalamine .375 g/1 Oral Capsule, Extended Release by Ascend Laboratories, LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.